Farley Brian E 4
4 · Neuronetics, Inc. · Filed Jul 5, 2018
Insider Transaction Report
Form 4
Farley Brian E
Director
Transactions
- Conversion
Common Stock
2018-07-02+8,483→ 84,065 total - Conversion
Common Stock
2018-07-02+15,342→ 99,407 total - Conversion
Common Stock
2018-07-02+1,506→ 110,438 total - Conversion
Series D Covertible Preferred Stock
2018-07-02−8,483→ 0 total→ Common Stock (8,483 underlying) - Conversion
Series E Covertible Preferred Stock
2018-07-02−15,342→ 0 total→ Common Stock (15,342 underlying) - Conversion
Series F Covertible Preferred Stock
2018-07-02−9,525→ 0 total→ Common Stock (9,525 underlying) - Conversion
Series G Covertible Preferred Stock
2018-07-02−1,506→ 0 total→ Common Stock (1,506 underlying) - Conversion
Common Stock
2018-07-02+9,525→ 108,932 total - Award
Stock Option Grant (Right to Buy)
2018-07-02+10,959→ 10,959 totalExercise: $5.22Exp: 2028-04-25→ Common Stock (10,959 underlying)
Footnotes (2)
- [F1]Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering.
- [F2]The performance criterion for vesting of this option was met upon the closing of the Issuer's initial public offering. One twelfth (1/12th) of the shares subject to the option vested or shall vest monthly commencing on March 16, 2018, subject to Reporting Person continuing to provide service through each such date.